These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7694655)

  • 21. The control of hyperacute rejection by genetic engineering of the donor species.
    White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
    Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease.
    Davies ME; Horner A; Loveland BE; McKenzie IF
    Scand J Rheumatol; 1994; 23(6):316-21. PubMed ID: 7528443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human DAF and MCP on pig endothelial cells protects from human complement.
    Carrington CA; Richards AC; Cozzi E; Langford G; Yannoutsos N; White DJ
    Transplant Proc; 1995 Feb; 27(1):321-3. PubMed ID: 7533398
    [No Abstract]   [Full Text] [Related]  

  • 24. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 26. Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18.
    Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
    Transplant Proc; 1994 Jun; 26(3):1251. PubMed ID: 7913260
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolonged survival of discordant xenografts in a subset of complement-depleted nude rats.
    Fryer JP; Chen S; Johnson EM; Simone P; Sun LH; Goswitz JJ; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):700. PubMed ID: 8623353
    [No Abstract]   [Full Text] [Related]  

  • 28. Glomerulonephritis and complement regulatory proteins.
    Nangaku M; Johnson RJ; Couser WG
    Exp Nephrol; 1997; 5(5):345-54. PubMed ID: 9386969
    [No Abstract]   [Full Text] [Related]  

  • 29. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of protection from humoral rejection by a xenografted liver.
    Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival.
    Schirmer JM; Fass DN; Byrne GW; Tazelaar HD; Logan JS; McGregor CG
    Xenotransplantation; 2004 Sep; 11(5):436-43. PubMed ID: 15303980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged survival of guinea pig hearts in rats after combined antibody and complement depletion.
    Scheringa M; Blanker R; Bemelman M; Schraa E; de Bruin R; Bouwman E; IJzermans J; Marquet R
    Transplant Proc; 1995 Feb; 27(1):303-4. PubMed ID: 7879011
    [No Abstract]   [Full Text] [Related]  

  • 34. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of complement suppression on xenograft survival in hyperacute rejection.
    Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
    Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein.
    Azimzadeh AM; Kelishadi SS; Ezzelarab MB; Singh AK; Stoddard T; Iwase H; Zhang T; Burdorf L; Sievert E; Avon C; Cheng X; Ayares D; Horvath KA; Corcoran PC; Mohiuddin MM; Barth RN; Cooper DK; Pierson RN
    Xenotransplantation; 2015; 22(4):310-6. PubMed ID: 26174749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants.
    Chen G; Sun QY; Wang XM; Shen SQ; Guo H; Wang H; Wu Y; Wang WY; Xiong YL; Chen S
    Xenotransplantation; 2004 Mar; 11(2):123-32. PubMed ID: 14962274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional expression of human CD59 in transgenic mice.
    Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ
    Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of C3 and C5 prolongs cardiac xenograft survival and decreases leukocyte infiltration in a model of delayed xenograft rejection.
    Johnson EM; Leventhal J; Dalmasso AP; Goswitz J; Simone P; Chen S; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):603. PubMed ID: 8623296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.